An Open-label Study to Assess the Safety of Repeat Administration of FX006 to Patients with Osteoarthritis of the Knee Save

Date Added
January 24th, 2017
PRO Number
Pro00062926
Researcher
Shane Woolf
Keywords
Arthritis, Drug Studies, Joint, Pain
Summary

The purpose of this study is to evaluate the safety of repeat administrations of the drug FX006 in patients who suffer from osteoarthritis of the knee. FX006 is a long lasting steroid that is injected into the knee for pain associated with osteoarthritis. Patients will be monitored monthly to ensure that they are benefiting from the injection.

Institution
MUSC
Recruitment Contact
Robert McClam
843-792-7238
mcclamr@musc.edu

Change_preferences

-- OR --

Create_login